Although GLP-1RAs are widely used, data concerning their safety during pregnancy, particularly with respect to fetal development, remain limited
Owen notes that While the impact of these medications could also be felt in metal packaging, this report does not cover that substrate, given that it is well positioned in emerging beverage segments and health-focused drinks. Heres what the data tells us: Circana estimates that by 2030, 35% of food and beverage units and 37% of nonfood units could come from GLP-1 households if current trends hold
Malhotra A, Grunstein RR, Fietze I, Weaver TE, Redline S, Azarbarzin A et al
Again, when you're figuring out your exact dosing measurements, having a reliable calculator makes life easier
Using patient reported outcomes in diabetes research and practice: recommendations from a national workshop